JULS

Accepting Submissions

The JULS is still accepting submissions for its 15th volume. Please consult the submissions page for more information regarding manuscript preparation and guidelines.

Click Here

New Developments at the JULS

The JULS is now hosted by the Journal Production Services at the University of Toronto. DOIs, ORCID, and Google Scholar indexing will be introduced for publications this year.

Click Here

JULS Volume 14 (Autumn 2020)

The 14th annual issue of JULS is in progress. Read about the formation of biological molecules in interstellar medium, approaches to counter insulin resistance, advances in machine learning and medical imaging, as well as student perspectives on undergraduate research.

Perspectives on Research

Describing obstacles, experiences, and tips for aspiring young scientists through an undergraduate and graduate perspective.

Latest Research

Ketene and Ammonia Forming Acetamide in the Interstellar Medium

Akash Kothari, Linglan Zhu, John Babi, Natalie J. Galant, Anita Rágyanszki & Imre G. Csizmadia

Kothari et al. investigates a reaction pathway that results in the creation of acetamide in the interstellar medium (ISM), which may support the formation of biological precursors of life.

Quantum Chemical Study of the Formation of Urea in Interstellar Medium

Linglan Zhu*, Akash Kothari*, John Babi, Natalie J. Galant, Anita Rágyanszki & Imre G. Csizmadia

Zhu et al. investigates the formation of urea, an essential biomolecule, in interstellar medium (ISM), which has implications on theories involving the origin of life.

A Pilot Study of Microbubble-Delivered Gene Therapy Using High Intensity Focused Ultrasound (HIFU)

Ain Kim & Seung-Hee Han

Oncolytic adenovirus is a frequently used viral vector for gene therapy in cancer treatments. However, they are highly susceptible to liver-drainage or rejection by the immune system upon injection. Kim et al investigates the possibility of minimally-invasive gene delivery using microbubbles with MRI-guided HIFU and confirms that the adenovirus can successfully be delivered into target tumor tissues.